Pulmonary disease in HIV-infected African children

International Journal of Tuberculosis and Lung Disease

Volumn 5, Issue 1, 2001, Pages 12-23

  Graham, S M ^a   Coulter, J B S ^a   Gilks, C F ^a  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

Author keywords

Africa; Bacterial pneumonia; Childhood; Human immunodeficiency virus; Lymphoid interstitial pneumonitis; Pneumococcus; Pneumocystis carinii; Pneumonia; Pulmonary tuberculosis

Indexed keywords

AFRICA; BACTERIAL PNEUMONIA; CAUSE OF DEATH; CHILD; CHILDHOOD MORTALITY; CLINICAL EXAMINATION; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTERSTITIAL PNEUMONIA; LUNG DISEASE; LUNG TUBERCULOSIS; MORBIDITY; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; REVIEW;

ACUTE DISEASE; AFRICA SOUTH OF THE SAHARA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; HUMANS; INFANT; LUNG DISEASES; MALE; RISK FACTORS;

EID: 0035028909     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. Prevention of mother-to-child transmission in resource-poor countries
2. Care of human immunodeficiency virus-infected children in developing countries
3. The challenge of providing effective care for HIV/AIDS in Africa
4. Care of children with HIV infection and AIDS in Africa
5. Natural history of human immunodeficiency virus type 1 infection in children: A five-year prospective study in Rwanda
6. Mortality after the first year of life among HIV-1 infected and uninfected children
7. Natural history of human immunodeficiency virus disease in perinatally infected children: An analysis from the pediatric spectrum of disease project
8. Natural history of vertically acquired human immunodeficiency virus-1 infection
9. Prognostic factors and survival in children with perinatal HIV-1 infection
10. The early natural history of vertically transmitted HIV-1 infection in African children from Durban, South Africa
11. The clinical challenge of the HIV epidemic in the developing world
12. Impact of human immunodeficiency virus type-1 on common pediatric illnesses in Zambia
13. Clinical spectrum of human immunodeficiency virus disease in children in a West African city
14. Morbidity among HIV-infected and uninfected African children
15. Children born to women with HIV-1 infection: Natural history and risk of transmission
16. Opportunistic infections in HIV-infected children
17. Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants
18. Disease in children infected with HIV in Abidjan, Cote d'Ivoire
19. Pulmonary manifestations in HIV seropositivity and malnutrition in Zimbabwe
20. Pneumocystis carinii and cytomegalovirus infections in severely ill, HIV-infected African infants
21. Mortality and pulmonary pathology of children with HIV infection in Francistown, Botswana
22. The clinical presentation and outcome of Pneumocystis carinii pneumonia in Malawian children
23. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory infections in human immunodeficiency virus type 1-infected children
24. Pneumocystis carinii pneumonia in Malawian children
25. Sputum induction for the diagnosis of tuberculosis
26. Sputum induction for the diagnosis of pulmonary tuberculosis in infants and young children in an urban setting in South Africa
27. Pneumocystis carinii pneumonia in South African children infected with human immunodeficiency virus
28. Persistent and chronic lung disease in HIV-1 infected and uninfected African children
29. Opportunistic infections and other clinical manifestations of HIV disease in children
30. Invasive bacterial infections in children born to women infected with human immunodeficiency virus type 1
31. Invasive pneumococcal disease among infected and uninfected children of mothers with human immunodeficiency virus infection
32. Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya
33. The management of pneumonia in children in developing countries
34. Efficacy and complications of transthoracic needle biopsy of lung in patients with Pneumocystis carinii pneumonia and AIDS
35. Acute lower respiratory infection in hospitalized children in Zimbabwe
36. The importance of enteric bacteria as a cause of pneumonia, meningitis, septicaemia among children in a rural community in the Gambia
37. Clinical presentation of non-typhoidal Salmonella bacteraemia in Malawian children
38. Life threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya
39. HIV-1 infection among malnourished children in Butare, Rwanda
40. The impact of human immunodeficiency virus type-1 infection on the presentation and case fatality rate of severe malnutrition
41. Infections in children with severe proteinenergy malnutrition
42. Bacterial pathogens in malnourished children with pneumonia
43. Bacterial infection in human immunodeficiency virus infected children
44. Antibiotic-resistant pneumococcal disease in South African children
45. Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae from Rwanda, 1984-1990
46. Streptococcus pneumoniae in human immunodeficiency virus type 1-infected adults
47. Streptococcus pneumoniae blood culture isolates with and without human immunodeficiency virus infection: Alterations in penicillin susceptibilities and in serogroups or serotypes
48. The clinical relevance of in-vitro resistance to penicillin, ampicillin, amoxycillin and alternative agents, for the treatment of community-acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis
49. Clinical implications of penicillin and ceftriaxone resistance among children with pneumococcal bacteremia
50. Pneumocystis carinii pneumonia in vertically acquired HIV infection in the British Isles
51. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1
52. Clinical and laboratory correlates of Pneumocystis carinii pneumonia in children infected with HIV
53. Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis pneumonia in the acquired immunodeficiency syndrome
54. Corticosteroids improve survival of children with AIDS and Pneumocystis carinii pneumonia
55. Effect of corticosteroids on survival of children with acquired immunodeficiency syndrome and Pneumocystis carinii-related respiratory failure
56. Virus infections of the respiratory tract in HIV-infected children
57. Respiratory syncytial virus infection in human immunodeficiency virus-infected children
58. Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis and Ureaplasma: A prospective study
59. Measles in hospitalised African children with human immunodeficiency virus
60. Simultaneous Pneumocystis carinii and pneumococcal pneumonia in human immunodeficiency virus-infected children
61. Cell mediated and humoral immune responses in children infected with human immuno-deficiency virus during the first four years
62. A double-blind, randomised and placebo controlled trial of 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults
63. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
64. Antibody responses to Haemophilus influenzae type b and Streptococcus pneumoniae vaccines in children with human immunodeficiency virus infection
65. Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection
66. Pulmonary lesions in children with the acquired immunodeficiency syndrome: A reappraisal based on data in additional cases and follow-up study of previously reported cases
67. Respiratory morbidity from lymphocytic interstitial pneumonitis (LIP) in vertically acquired HIV infection
68. Pediatric HIV infection in its second decade - The changing pattern of lung involvement
69. Survival in children with perinatally acquired immunodeficiency virus type 1 infection
70. Corticosteroid treatment for pulmonary lymphoid hyperplasia in children with acquired immunodeficiency syndrome
71. Bronchiectasis in pediatric AIDS
72. Clinical and endocrinological manifestations in perinatally human immunodeficiency virus type 1-infected children aged 5 years and older
73. Culture-positive tuberculosis in human immunodeficiency virus type-1-infected children
74. The mortality and pathology of HIV infection in a West African city
75. The pattern of tuberculosis in Queen Elizabeth Central Hospital, Blantyre, Malawi: 1986-1995
76. Childhood human immunodeficiency virus and tuberculosis co-infections: Reconciling conflicting evidence
77. Childhood TB/HIV co-infection: Correction, confusion and compliance
78. Human immunodeficiency virus type-1 infection in Zambian children with tuberculosis: Changing seroprevalence and evaluation of a thiacetazone free regimen
79. Tuberculosis and HIV infection in children in Abidjan, Cote d'Ivoire
80. Impact of HIV infection on the development, clinical presentation and outcome of tuberculosis among children in Abidjan, Cote d'Ivoire
81. Tuberculin reactivity in a pediatric population with high BCG vaccination coverage
82. Childhood tuberculosis
83. Procedures for developing a simple scoring method based on unsophisticated criteria for screening children for tuberculosis
84. Tuberculosis score Chan in children in Aitape, Papua New Guinea
85. Detection of Mycobacterium tuberculosis in nasopharyngeal aspirate samples in children
86. Human immunodeficiency virus infection in children with tuberculosis in Santo Domingo, Dominican Republic: Prevalence, clinical findings, and response to anti-tuberculosis treatment
87. Effects of the human immunodeficiency virus on tuberculosis in children
88. Clinical presentation of pulmonary tuberculosis in under 10s and differences in AIDS-related cases: A cohort study of 115 patients
89. Diagnosis of pulmonary tuberculosis in children in an HIV endemic area, Malawi
90. Ethambutol usage in tuberculosis - Time to reconsider?
91. Childhood tuberculosis in an urban population in South Africa: Burden and risk factors
92. Lymph node biopsies in HIV-infected and non-infected children with persistent lung disease